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HOW EARLY DO ANTIBIOTICS HAVE TO BE TO IMPACT
MORTALITY IN SEVERE SEPSIS? A PROSPECTIVE,
OBSERVATIONAL STUDY FROM AN EMERGENCY DEPARTMENT
Shahla Siddiqui, Nawal Salahuddin*, Adeel Raza*, Junaid Razzak**
Department of Anaesthesia, *Section of Pulmonary & Critical Care Medicine, **Section of Emergency Medicine, Department of
Medicine, Aga Khan University, Karachi, Pakistan

Background: The objective of this study was to assess the promptness of antibiotic administration to
patients presenting with sepsis and the effects on survival and length of hospitalization. Methods:
Consecutive, adult patients presenting with Systemic Inflammatory Response Syndrome (SIRS) to
the emergency department of the Aga Khan University hospital were enrolled in a prospective,
observational study over a period of 4 months. Univariate, multivariate regression modeling and oneway ANOVA were used to examine the effects of various variables on survival and for significant
differences between timing of antibiotic administration and survival, two-sided p values <0.05 were
considered significant. Results: One hundred and eleven patients were enrolled. Severe sepsis was
present in 52% patients; the most frequent organism isolated was Salmonella typhi (18%). Overall
mortality was 35.1%. One hundred (90.1%) patients received intravenous antibiotics in the
Emergency room; average time from triage to actual administration was 2.48±1.86 hours. The timing
of antibiotic administration was significantly associated with survival (F statistic 2.17, p=0.003).
Using a Cox Regression model, we were able to demonstrate that survival dropped acutely with
every hourly delay in antibiotic administration. On multivariate analysis, use of vasopressors
(adjusted OR 23.89, 95% CI 2.16,263, p=0.01) and Escherichia coli sepsis (adjusted OR 6.22, 95%
CI 1.21,32, p=0.03) were adversely related with mortality. Conclusions: We demonstrated that in
the population presenting to our emergency room, each hourly delay in antibiotic administration was
associated with an increase in mortality.
Keywords: sepsis, shock, antibiotics, emergency department

INTRODUCTION
Severe sepsis and septic shock are common conditions
that lead to hospitalisation. Though data from Pakistan
is almost nonexistent, it is estimated that about 2.9% of
hospital admissions and 10% of intensive care unit
admissions are due to severe sepsis.1,2 Also, perhaps
more significantly, more than half of such cases initially
present to the emergency department.3
Despite improvements in health care services,
the mortality rate from severe sepsis and shock remains
high exceeding 30% in the West and 60% in the
developing world.4,5 Initiating effective antibiotic
therapies in severe sepsis and shock is proven to lead to
better outcomes. The Surviving Sepsis Campaign7
developed in 2004, incorporated evidence-based
guidelines to reduce mortality from severe sepsis and
septic shock. These include the early initiation of broad
spectrum antimicrobials, i.e., within 1 hour of
recognition of sepsis.
Unfortunately guidelines are not always
immediately incorporated. There are delays in
recognition of disease states and in institution of
therapy, especially in the emergency room setting where
patient volumes and time constraints put additional
burdens on the care providers.8
The objective of this study was to assess the
compliance with the Surviving Sepsis Guidelines in our
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Emergency department and the subsequent effects on
length of hospitalisation and survival.

MATERIAL AND METHODS
This was a prospective, observational study that enrolled
consecutive adult patients presenting with Systemic
Inflammatory Response Syndrome to the emergency
department of the Aga Khan University hospital. The
study extended period from February–June 2008.
Patient enrolment was by convenience sampling.
Systemic Inflammatory Response Syndrome
(SIRS) was defined according to the criteria proscribed
by the Society of Critical Care Medicine9,10, i.e., patients
presenting with any two clinical signs, tachypnoea,
sinus tachycardia, body temperature <35 °C or >38 °C,
white blood cell counts <4,000 or >10,000. Sepsis was
defined as the presence of any 2 or more SIRS criteria in
the setting of a documented or presumed infection.
Severe sepsis was defined by concomitant organ
dysfunction and Septic shock in the presence of
accompanying sustained hypotension (<90 mm Hg
systolic blood pressure or <65 mm Hg mean arterial
pressure) despite adequate fluid resuscitation.
Antibiotics were considered appropriate if on
subsequent culture, the organism demonstrated in vitro
sensitivity to that antibiotic.
A research officer stationed in the emergency
room identified patients. Exclusion criteria were age
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<18 years, patients transferred from other hospitals or
chronic care facilities or those already receiving
antibiotics. Demographic and study-specific data were
collected. The patient was followed until either death or
discharge.
The study protocol was approved by the
Hospital Ethical Review Committee.
Continuous data is expressed as Mean±SD,
categorical data is expressed as percentages. The
primary outcome variable was survival to hospital
discharge and the secondary outcome was length of
hospitalisation. Univariate and multivariate regression
modeling were used to examine the effects of various
variables on survival. Chi-square test, or Fisher’s exact
test where appropriate, and one-way ANOVA were
used to check for significant differences between
timings of antibiotic administration and survival; twosided p<0.05 were considered significant. All analyses
were carried out using SPSS version 14.0.

RESULTS
One hundred and eleven patients were enrolled in the
study; the average age was 69 years, 56% were males.
All patients met criteria for SIRS at enrolment; sepsis
was later confirmed by cultures in 96 (86.4%) patients.
Fourteen patients (14.6%) were in shock. Figure-1
illustrates the distribution of patients according to
severity of Sepsis or those in SIRS.
SIRS alone
14%

sepsis
18%

septic shock
16%

frequently administered antibiotic in the ED was
Ceftriaxone (46.8%) followed by other cephalosporins
(cefixime, cefipime) in 15.7%, fluroquinolones
(ciprofloxacin,
levofloxacin)
in
13.5%
and
metronidazole, vancomycin, clindamycin together
accounted for 14.7%. Ampicillin, cloxacillin,
amoxicillin with beta lactamase inhibitors were used in
only 6.6% and aminoglycosides in 2.7%. On subsequent
culture reports, it was confirmed that 65 (67.7%)
patients received appropriate antibiotics.
Of all the patients presenting with SIRS, only
62 (55.9%) received 1 litre or more of intravenous fluid
resuscitation in less than 4 hours. Vasopressors were
used in 14 (12.6%) patients. Overall mortality with
Sepsis was 34.2% (38 patients), with a mean length of
hospitalisation of 4.78±3.41 days (range <1–14 days).
Table-1: Types of organisms isolated from patients
with sepsis
Organism
Pneumococcus
Escherichia coli
Salmonella typhi
Klebsiella
Staphylococcus
Pseudomonas
Candida
Bacteroides
No growth

Frequency
6
14
18
5
7
4
4
2
2

Percent
5.4
12.6
16.2
4.5
6.3
3.6
3.6
1.8
1.8

The timing of antibiotic administration was
significantly associated with survival (F statistic 2.17,
p=0.003). Using a Cox Regression model, we were able
to demonstrate that survival dropped acutely with every
hourly delay in antibiotic administration (Figure-2).
Cumulative
Survival

1.0
0.8
0.6
0.4
0.2
severe sepsis
52%

Figure-1: Distribution of patients with sepsis
The most common cause of sepsis, as shown
in Table-1, was bloodstream infections in 65 patients
(67.7%), followed by pneumonia in 21 (21.9%) and
meningitis in 10 (10.4%). Salmonella typhi (17.7%) and
Escherichia coli (12.5%) were the most frequent
organisms isolated. Over 40% of the patients had no
organism isolated on culture. Other organisms were;
Staphylococcus, aureus (7%), Pneumococcus (6%),
Klebsiella (5%), Pseudomonas aeruginosa (4.5%)
candida albicans (3%).
One hundred (90.1%) patients received
intravenous antibiotics in the Emergency Department
(ED), the mean time from ED registration to actual
administration was 2.48±1.86 hours. The most
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Figure-2: Cox regression model showing a drop in
cumulative survival with delays in antibiotic
administration
Table-2 shows the univariate regression
analysis indicated significant associations between
increased
mortality
and
delayed
antibiotic
administration, need for vasopressors, Escherichia coli
or Candida septicaemia and inability to receive greater
than 1 litre fluid resuscitation within 4 hours of
presentation to the emergency room. On multivariate
analysis, as shown in Table-3, use of vasopressors
(adjusted odds ratio 23.89, 2.16–263, p=0.01) and
Escherichia coli sepsis (adjusted odds ratio 6.22, 1.21–
32, p=0.03) were adversely related with mortality.
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Table-2: Univariate analysis of risk factors for an increased in-hospital Mortality in patients presenting with Sepsis
Factor
Timing of Antibiotic administration
Length of hospitalisation
Culture result
Positive
Negative
IV fluids >1L within 4 hours
Yes
No
Appropriate antibiotics given
Yes
No
Vasopressors used
Yes
No
Escherichia coli sepsis
Candida sepsis

Death (%)
n=38
3 hrs±1.47
4.84 days±3.2

Discharge (%)
n=73
2.20±2 hours
4.75±3.5 days

Crude OR
0.79
0.99

95% CI
0.63, 0.98
0.88, 1.14

p value
0.04
0.89

28 (73.7)
10 (26.3)

42 (57.5)
31 (42.5)

0.48
1.0

0.20, 1.14

0.09

30 (78.9)
8 (21.1)

32 (43.8)
41 (56.2)

0.20
1.0

0.08, 0.51

0.001

37 (97.4)
1 (2.6)

63 (86.3)
10 (13.7)

0.17

0.02, 1.38

0.09

12 (31.6)
26 (68.4)
11 (78.5%)
3 (75%)

2 (2.7)
71 (97.3)
3 (21.4%)
1 (25%)

0.06
15.03
12.3

0.01, 0.29
3.52 , 64
1.15 , 131

<0.001
<0.000
0.03

Table-3: Multivariate logistic regression model of
factors associated with an increased likelihood of
survival to hospital discharge in patients with Sepsis
Adjusted
95%
Characteristics
OR
CI
p
Timing of Antibiotic administration
0.84
0.65, 1.08 0.18
IV fluids >1L within 4 hours
Yes
0.24
0.09, 0.65 0.005
No
1.0
Vasopressors
Used
0.07
0.01, 0.37 0.002
Not used
-2 log likelihood=112.572, p=0.95

Mortality in the subgroup that presented with
Septic shock was 100%; 37.5% of patients presented
with septicaemia alone whilst 25% patients had a preexisting pneumonia. The most frequent organism
isolated was Escherichia coli (37.5%) followed by
Salmonella typhi (31.3%) and pseudomonas (12.5%).
Only 62.5% patients received appropriate antibiotics as
proved by subsequent cultures. Average time for
antibiotic administration was 3.63±1.44 hours. The
majority of patients received appropriate aggressive
resuscitative care; 100% received antibiotics and 81%
greater than 1 litre of intravenous fluids within 4 hours
of presentation. However, only 50% received
vasopressor support in the emergency room.

DISCUSSION
Our results show that the earlier an appropriate
antibiotic is administered, the better the chances for
survival in sepsis. We demonstrated that in the
population presenting to our emergency room, each
hourly delay in antibiotic administration was
associated with an increase in mortality.
The biggest challenge in sepsis is early
recognition of the problem. The presentation of
severe sepsis and septic shock can initially be nonspecific, but can progress within hours to fulminant
multiple organ failure and death.11 Patients presenting
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to the emergency department with sepsis may not
receive timely or appropriate antibiotics since the
diagnoses of systemic inflammatory response
syndrome (SIRS) as well as sepsis are often missed.12
Delays in the identification, transfer and management
of critically ill patients during the first 6 hours after
admission have been associated with higher mortality
rates13 and increased utilisation of hospital
resources14. Antimicrobial selection is often random
and erratic. Delaying antibiotic administration maybe
related to worsened clinical outcomes.15 Patients
eventually arrive in the intensive care unit in a
moribund state with profound shock and multi-organ
failure.16,17
Better understanding of the pathophysiology of
sepsis has led to recommendations which target both
early and goal-directed management to improve
outcomes.18 The timeliness of treatment became
apparent after Rivers et al19 showed a significant
mortality benefit when heamodynamic optimization was
provided within the first few hours of disease
presentation. These ideals have been incorporated into
the Surviving Sepsis Campaign, a multinational
initiative, which recommends a 24-hour sepsis pathway
that includes a critical 6-hour course of action.7
Results of studies from predominantly
Europe and North America document the mortality
and morbidity benefits of both early and appropriate
antimicrobials.20,21,24–26 Kollef et al20 in their
landmark paper on 2000 patients with both
community-acquired and nosocomial infections,
demonstrated that inadequate antimicrobial treatment
of infection was the most important independent
determinant of hospital mortality for the entire patient
cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44;
p<0.001). Observational studies suggest a significant
reduction in mortality when antibiotics are
administered within 4 22 and 8 hours23 of hospital
presentation (p<0.01). In our study we also were able

http://www.ayubmed.edu.pk/JAMC/PAST/21-4/Shahla.pdf

J Ayub Med Coll Abbottabad 2009;21(4)

to demonstrate a statistically significant relationship
between early administration of antibiotics and
survival, the crude odds ratio of 0.70 (95% CI, 0.63 to
0.98, p=0.04) indicates a protective effect when
antibiotics were given early.
Our study is unique since it is the first study
from the Indian Subcontinent to address the issue of
timely antibiotic administration in the ED setting.
Our study population also differs from those in other
trials by the overwhelming prevalence of blood
stream sepsis with Salmonella typhi, which in itself
had an unadjusted mortality rate of 18%. However
our results are comparable to other studies, with
similar rates of appropriate antibiotic administration
(64% comparable to the 63%–84% reported in the
literature27–31) and overall mortality.
In our study, aggressive intravenous fluid
resuscitation was carried out in almost half the
patients presenting with sepsis but less than that
recommended by the guidelines.7 The average timing
of antibiotics delivered in septic shock patients was
2.3 hours. Kumar et al32 recently published a
recommendation to start broad spectrum antibiotics
in septic shock patients within an hour of onset of
hypotension. We are not alone in our non-adherence
to guidelines. Literature from the West also suggests
that adherence is improved by instituting protocols
and order sets. Micek et al33 recently reported that
only after implementation of a standardised protocol
did their ED resuscitative measurers approach those
recommended by the Surviving Sepsis Guidelines.
Although our survival rates are well within
international standards and our timing of initiation of
antimicrobial therapy may be acceptable, 100% of
our septic shock patients died. Though the numbers
are too small to draw concrete conclusions, it would
seem likely that the excess mortality may have been
related to inappropriate choices of antibiotics and a
lack of goal-directed fluid resuscitation.
One important limitation of our study is that
only 67% patients received appropriate antibiotics in
the emergency room. This underscores the importance
of recognizing and documenting local microbiological
patterns of pathogenicity and drug sensitivity.
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